Cargando…

The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysis

Studies to confirm the effect of acknowledged prognostic markers in older breast cancer patients are scarce. The aim of this study was to evaluate the prognostic value of HER-2 overexpression and PIK3CA mutations in older breast cancer patients. Female breast cancer patients aged 65 years or older,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Engels, Charla C., Kiderlen, Mandy, Bastiaannet, Esther, van Eijk, Ronald, Mooyaart, Antien, Smit, Vincent T. H. B. M., de Craen, Anton J. M., Kuppen, Peter J. K., Kroep, Judith R., van de Velde, Cornelis J. H., Liefers, Gerrit Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2016
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819549/ https://www.ncbi.nlm.nih.gov/pubmed/26968397 http://dx.doi.org/10.1007/s10549-016-3734-y

Ejemplares similares

Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study
por: Reimers, Marlies S, et al.
Publicado: (2014)

Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer
por: Mieog, J Sven D, et al.
Publicado: (2012)

Treatment Strategies and Survival of Older Breast Cancer Patients – An International Comparison between the Netherlands and Ireland
por: Kiderlen, Mandy, et al.
Publicado: (2015)

Effect of implementation of the mass breast cancer screening programme in older women in the Netherlands: population based study
por: de Glas, Nienke A, et al.
Publicado: (2014)

No Excess Mortality in Patients Aged 50 Years and Older Who Received Treatment for Ductal Carcinoma In Situ of the Breast
por: Bastiaannet, Esther, et al.
Publicado: (2012)

Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma
por: Engels, C C, et al.
Publicado: (2014)

Biomarkers in precision therapy in colorectal cancer
por: Reimers, Marlies S., et al.
Publicado: (2013)

Contralateral breast cancer risk in relation to tumor morphology and age—in which patients is preoperative MRI justified?
por: de Glas, N. A., et al.
Publicado: (2015)

Validity of the online PREDICT tool in older patients with breast cancer: a population-based study
por: de Glas, N A, et al.
Publicado: (2016)

Surgical treatment of early stage breast cancer in elderly: an international comparison
por: Kiderlen, M., et al.
Publicado: (2011)

The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis
por: Frouws, Martine A., et al.
Publicado: (2017)

Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer
por: Blok, Erik J., et al.
Publicado: (2017)

Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?
por: Charehbili, Ayoub, et al.
Publicado: (2013)

The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis
por: Engels, C. C., et al.
Publicado: (2015)

Inclusion and Analysis of Older Adults in RCTs
por: Van de Water, W., et al.
Publicado: (2011)

The Prognostic Value of the Apoptosis Pathway in Colorectal Cancer: A Review of the Literature on Biomarkers Identified by Immunohistochemistry
por: Zeestraten, Eliane C.M., et al.
Publicado: (2013)

Nuclear Localization of CXCR4 Determines Prognosis for Colorectal Cancer Patients
por: Speetjens, Frank M., et al.
Publicado: (2008)

Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy
por: de Groot, A. F., et al.
Publicado: (2019)

Cytoplasmic Overexpression of HER2: a Key Factor in Colorectal Cancer
por: Blok, Erik J, et al.
Publicado: (2013)

Revising the Role of Integrin Subunit β4 Expression in Colon Cancer Progression and Survival
por: Rademaker, Eva, et al.
Publicado: (2022)

The effect of aspirin and nonsteroidal anti-inflammatory drug use after diagnosis on survival of oesophageal cancer patients
por: van Staalduinen, Jente, et al.
Publicado: (2016)

NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study
por: de Kruijf, Esther M, et al.
Publicado: (2012)

Risk Factors for Excess Mortality in the First Year After Curative Surgery for Colorectal Cancer
por: Gooiker, Gea A., et al.
Publicado: (2012)

Tumor LINE-1 Methylation Level in Association with Survival of Patients with Stage II Colon Cancer
por: Swets, Marloes, et al.
Publicado: (2016)

Variation in treatment and survival of older patients with non-metastatic breast cancer in five European countries: a population-based cohort study from the EURECCA Breast Cancer Group
por: Derks, Marloes G. M., et al.
Publicado: (2018)

Genetic Concordance in Primary Cutaneous Melanoma and Matched Metastasis: A Systematic Review and Meta-Analysis
por: Kerkour, Thamila, et al.
Publicado: (2023)

Relevant factors for the optimal duration of extended endocrine therapy in early breast cancer
por: Blok, Erik J., et al.
Publicado: (2017)

No association between metformin use and survival in patients with pancreatic cancer: An observational cohort study
por: Frouws, Martine A., et al.
Publicado: (2017)

Early stage breast cancer treatment and outcome of older patients treated in an oncogeriatric care and a standard care setting: an international comparison
por: de Boer, Anna Z., et al.
Publicado: (2020)

High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients
por: Derr, Remco S, et al.
Publicado: (2014)

Primary Melanoma Characteristics of Metastatic Disease: A Nationwide Cancer Registry Study
por: Zhou, Catherine, et al.
Publicado: (2021)

The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute⊕ Study
por: Lips, Daniel J, et al.
Publicado: (2011)

Prevalence and Risk Factors of Ovarian Metastases in Breast Cancer Patients < 41 Years of Age in the Netherlands: A Nationwide Retrospective Cohort Study
por: Peters, Inge T. A., et al.
Publicado: (2017)

Use of Aspirin postdiagnosis improves survival for colon cancer patients
por: Bastiaannet, E, et al.
Publicado: (2012)

Improved survival of older patients with advanced breast cancer due to an increase in systemic treatments: a population-based study
por: de Glas, Nienke, et al.
Publicado: (2019)

Trichoblastic carcinosarcoma with panfollicular differentiation (panfollicular carcinosarcoma) and CTNNB1 (beta‐catenin) mutation
por: Giang, Jenny, et al.
Publicado: (2020)

Prognostic value of tumor–stroma ratio combined with the immune status of tumors in invasive breast carcinoma
por: Vangangelt, K. M. H., et al.
Publicado: (2017)

Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile
por: Krijgsman, Daniëlle, et al.
Publicado: (2019)

Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
por: Zeestraten, E C M, et al.
Publicado: (2014)

Tread carefully when considering vulvar melanoma in a child or adolescent
por: Morrel, Beth, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eobd20dsrd8tu5ndel9769mvm2